Orakl Oncology
Techbio platform leveraging the smartest collection of tumour avatars to transform oncology drug development
Villejuif, Francewww.orakl-oncology.com ↗
Total raised
€14M
€14,000,000
Funding rounds
2
Investors
7
distinct backers
Active since
2023-10
latest 2024-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood54
base rate 44% for Seed
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-12-03 | Seed | €11M | Bpifrance,Existing investors,Grand Prix i-Lab,Singular | View deal → |
| 2023-10-05 | Other | €3.0M | HCVC,Speedinvest,Verve Ventures | View deal → |
Related news
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software